Aimmune Therap (AIMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,817 | -3,441 | -11,120 | -7,486 | -4,357 |
| Depreciation Amortization | 30 | 11 | 20 | 15 | 11 |
| Accounts payable and accrued liabilities | -169 | 499 | N/A | 586 | 278 |
| Other Working Capital | 1,004 | -589 | 1,230 | 885 | 36 |
| Other Operating Activity | 1,158 | -473 | 100 | -538 | -247 |
| Operating Cash Flow | $-8,794 | $-3,993 | $-9,770 | $-6,538 | $-4,279 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -596 | -44 | -50 | -51 | -44 |
| Other Investing Activity | -60 | 0 | -40 | -40 | -40 |
| Investing Cash Flow | $-656 | $-44 | $-90 | $-91 | $-84 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 65,683 | 67,081 | 190 | 0 | 0 |
| Financing Cash Flow | $65,683 | $67,081 | $190 | $N/A | $N/A |
| Beginning Cash Position | 2,269 | 2,269 | 11,950 | 11,951 | 11,951 |
| End Cash Position | 58,502 | 65,313 | 2,260 | 5,322 | 7,588 |
| Net Cash Flow | $56,233 | $63,044 | $-9,680 | $-6,629 | $-4,363 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,794 | -3,993 | -9,770 | -6,538 | -4,279 |
| Capital Expenditure | -596 | -44 | N/A | -51 | -44 |
| Free Cash Flow | -9,390 | -4,037 | -9,770 | -6,589 | -4,323 |